Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penicillamine, Low Copper Diet, and Radiation Therapy in Newly Diagnosed Glioblastoma
NCT00003751Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 1999
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of penicillamine in glioblastoma (GBM), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoints: Overall Survival up to 2 years and Time to Progression up to 2 years. Started Mar 1999; status: completed.
02
Drugs
penicillamine
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT00003751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003751.